Pharmacology Books

6014 products


  • The Opioid Fix

    Johns Hopkins University Press The Opioid Fix

    Book SynopsisWhy medication-assisted treatment, the most effective tool for battling opioid addiction, is significantly underused in the United States. Bronze Winner of the 2021 IPPY Book Award in Health/Medicine/Nutrition, Gold Winner of the 2020 Foreword INDIES Award in HealthAmerica's addiction crisis is growing worse. More than 115 Americans die daily from opioid overdoses, with half a million deaths expected in the next decade. Time and again, scientific studies show that medications like Suboxone and methadone are the most reliable and effective treatment, yet more than 60 percent of US addiction treatment centers fail to provide access to them. In The Opioid Fix, Barbara Andraka-Christou highlights both the promise and the underuse of medication-assisted treatment (MAT). Addiction, Andraka-Christou writes, is a chronic medical condition. Why treat it, then, outside of mainstream medicine? Drawing on more than 100 in-depth interviews with people in recovery, their family members, treatment Trade ReviewThis book should be required reading for every American having any role in developing or implementing drug policy—perhaps that should include every registered voter.—Caroline Jean Acker, Ph.D., Professor Emerita of History at Carnegie Mellon University, author of Creating the American Junkie: Addiction Research in the Classic Era of Narcotic ControlTable of ContentsIntroductionChapter 1. What's Nixon Got to Do with It? A History of Medication-Assisted Treatment Chapter 2. A Strained Relationship: Alcoholics Anonymous and Medication-Assisted TreatmentChapter 3. The Perils and Promises of Treatment CentersChapter 4. Methadone Clinics: Maintaining Stigma for DecadesChapter 5. The Elusive Addiction-Treating PhysicianChapter 6. When Criminal Justice Administrators Make Medical DecisionsChapter 7. Learning from Other CountriesConclusionAcknowledgments ReferencesIndex

    £21.38

  • Building Breakthroughs

    Johns Hopkins University Press Building Breakthroughs

    Book SynopsisFrom mRNA vaccines to gene therapies, the next frontier of medical innovation is here. In Building Breakthroughs, Raju Prasad tells the story of important advancements in biotechnology and medical innovation from gene therapies to mRNA vaccines, providing historical context and examining cutting-edge research. Based on in-depth interviews with both the scientists who developed these discoveries and the patients who have benefited from them, Building Breakthroughs reveals the key players behind drug development and the inner workings of this essential business. Through stories of patients and their families, and of the researchers creating new treatments, Prasad reveals how cell therapies are advancing to treat childhood leukemia and a form of lymphoma, how a gene therapy was established to treat the rare disease spinal muscular atrophy type I, and potentially curative therapies that are being developed for sickle cell disease. By examining the clinical trial and regulatory paths eachTable of ContentsIntroductionPart I. The Journey from Idea to ApprovalChapter 1. Leukemia and LymphomaChapter 2. Chimeric Antigen Receptor (CAR)-T Cell TherapyChapter 3. Spinal Muscular AtrophyChapter 4. In Vivo Gene TherapyChapter 5. Sickle Cell AnemiaChapter 6. Ex Vivo Gene-Modified Cell TherapyChapter 7. A Brief History of FDA RegulationChapter 8. The Path to ApprovalPart II. Enabling the Next Wave Of InnovationChapter 9. Building Blocks Chapter 10. Recognizing ValueChapter 11. Financial and Human Capital Investments in BiotechnologyChapter 12. Looking ForwardEpilogue. COVID-19AcknowledgmentsReferencesIndex

    £20.70

  • Springer-Verlag New York Inc. PharmacokineticPharmacodynamic Modeling and Simulation

    3 in stock

    Book SynopsisThis is a second edition to the original published by Springer in 2006. The comprehensive volume takes a textbook approach systematically developing the field by starting from linear models and then moving up to generalized linear and non-linear mixed effects models. Since the first edition was published the field has grown considerably in terms of maturity and technicality. The second edition of the book therefore considerably expands with the addition of three new chapters relating to Bayesian models, Generalized linear and nonlinear mixed effects models, and Principles of simulation. In addition, many of the other chapters have been expanded and updated.Table of ContentsThe Art of Modeling.- Linear Models and Regression.- Nonlinear Models and Regression.- Variance Models, Weighting, and Transformations.- Case Studies in Linear and Nonlinear Modeling.- Linear Mixed Effects Models.- Nonlinear Mixed Effects Models: Theory.- Nonlinear Mixed Effects Models: Practical Issues.- Nonlinear Mixed Effects Models: Case Studies.- Bayesian Modeling.- Generalized Linear Models and Its Extensions.- Principles of Simulation.- Appendix.- Index

    3 in stock

    £197.99

  • An Introduction to Toxicology

    Springer London Ltd An Introduction to Toxicology

    1 in stock

    Book SynopsisThe Emergence of Modern Toxicology.- Core Concepts in Toxicology.- Toxicokinetics - The Fate of Chemicals within the Body.- Toxicodynamics - How Chemicals Induce Toxicity.- Fightback - Adaptive Responses to Toxicant Exposure.- Target Organ Toxicity: Liver and Kidney.- Chemical Toxicity to the Unborn.-Chemicals and Cancer.-Everyday Toxicology I - Alcohol.-Everyday Toxicology II - Tobacco. ? ? ?Trade ReviewFrom the book reviews:“I found this to be an excellent text book, in fact one of the best I have referred to in recent times. Whether one is a non-toxicologist seeking an overview of the subject or an Industrial Toxicologist working every day to tackle the issues of product development, there is something for everybody. … This book should be a point of reference for any modern toxicologist – it will be for me!” (Jim Ridings, bts News Magazine of The British Toxicology Society, Vol. 1 (2), September, 2014)Table of ContentsThe Emergence of Modern Toxicology.- Core Concepts in Toxicology.- Toxicokinetics - The Fate of Chemicals within the Body.- Toxicodynamics - How Chemicals Induce Toxicity.- Fightback - Adaptive Responses to Toxicant Exposure.- Target Organ Toxicity: Liver and Kidney.- Chemical Toxicity to the Unborn.- Chemicals and Cancer.- Everyday Toxicology I - Alcohol.- Everyday Toxicology II - Tobacco. ​ ​ ​

    1 in stock

    £71.24

  • LCMS in Drug Bioanalysis

    Springer Us LCMS in Drug Bioanalysis

    3 in stock

    Book SynopsisThis book covers the various methods of validation for high performance liquid chromatography - mass spectrometry (LC-MS) analytical techniques and their applications in the analysis of a broad range of drugs in modern clinical pharmacology.Table of ContentsInternal standards for quantitative LC-MS bioanalysis.- Method development, validation and sample analysis for regulated quantitative bioanalysis using LC-MS/MS.- Impact of sampling paper/cards on bioanalytical quantitation via dried blood spots by liquid chromatography - mass spectrometry.- Highly sensitive pharmaceutical and clinical analysis using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry.- Pitfalls of LC-MS/MS in the clinical laboratory.- Therapeutic drug monitoring to support clinical pharmacogenomics.- Liquid chromatography - mass spectrometry for the determination of antidepressants and some of their major metabolites in human biological matrices.- The analysis of antipsychotic drugs in human biosamples by LC-MS.- Therapeutic drug monitoring of targeted anticancer therapy - tyrosine kinase inhibitors and selective oestrogen receptor modulators: a clinical pharmacology laboratory perspective.- Applications of mass spectrometry in analyses of steroid hormones.- Liquid chromatography - mass spectrometric analysis of tropane alkaloids in mammalian samples: techniques and applications.- Analysis of illicit drugs in human biological samples by LC-MSn.- Use of matrix assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) in the development of novel small molecule drugs.- A planar integrated micro mass spectrometer.

    3 in stock

    £87.99

  • Clinical Pharmacology in Athletic Training

    Human Kinetics Publishers Clinical Pharmacology in Athletic Training

    1 in stock

    Book SynopsisAthletic trainers have a responsibility to provide high-quality pharmaceutical care while meeting both legal and ethical requirements. Clinical Pharmacology in Athletic Training empowers athletic trainers with a functional understanding of pharmacology that enables them to formulate a treatment plan intended to mitigate disease and improve the overall health of their patients. This text incorporates the most up-to-date content from the 2020 Commission on Accreditation of Athletic Training Education (CAATE) standards, and it emphasizes interprofessional practice to enable future and current athletic trainers to collaborate with other health professionals in a manner that optimizes the quality of care.Clinical Pharmacology in Athletic Training begins by addressing drug legislation and the legal aspects of the athletic trainer’s role in sport medication. The text provides an overview of pharmacokinetics and pharmacodynamics with an emphasis on concepts releTable of ContentsPart I. Foundational Pharmacology ConceptsChapter 1. Legal Aspects of Therapeutic Medication ManagementHealth Care Providers With Prescribing AuthorityThe Sports Medicine TeamFederal and State LawsDrug Development, Studies, and StandardsSummaryCase StudiesChapter 2. Administering Medications in the Athletic Training SettingAthletic Training ClinicGuidelines for Administering MedicationsPreventing Medication ErrorsSummaryCase StudiesChapter 3. Drug Names, Classification, and SafetyDrug NamesDrug ClassesDrug SafetyAdverse Drug Effects and Therapeutic MonitoringAllergic Drug ReactionsMedication Use ProcessDrug Information ResourcesSummaryCase StudiesChapter 4. PharmacokineticsBiopharmaceuticsDrug LiberationDrug AbsorptionDrug DistributionDrug MetabolismDrug EliminationPharmacokinetics and ExerciseSummaryCase StudiesChapter 5. PharmacodynamicsMechanism of ActionDrug ReceptorsDrug–Receptor BindingDrug–Receptor InteractionsDrug DosingDose ResponsesSummaryCase StudiesChapter 6. Drug Delivery, Dosages, and ProceduresDrug Delivery SystemsRoutes of AdministrationEnteral Drug DeliveryParenteral Drug DeliveryMucous Membrane Drug AdministrationTopical Drug AdministrationTransdermal Drug AdministrationMedication DosingClinical Procedures for Enteral Drug AdministrationSummaryCase StudiesPart II. Classes of Therapeutic MedicationsChapter 7. Drugs to Treat Pain: Nonopioid Analgesics and AnestheticsBiopsychosocial ModelDifferentiation of PainPathophysiology of PainAnalgesicsNonopioid Analgesic AgentsLocal AnestheticsTopical Analgesics: Creams, Gels, and OintmentsThe ATs’ Role in the Clinical Management of PainSummaryCase StudiesChapter 8. Drugs to Treat Pain: Opioid AnalgesicsAppropriate Use of Opioid AnalgesicsClasses of Opioid AnalgesicsSummaryCase StudiesChapter 9. Drugs to Treat Inflammation: Steroidal and Nonsteroidal Anti-InflammatoriesInflammatory ProcessControlling InflammationCorticosteroidsNonsteroidal Anti-Inflammatory DrugsSummaryCase StudiesChapter 10. Drugs to Treat Infection: AntibioticsIndications for UseMechanism of ActionTherapeutic EffectsRoutes of AdministrationPharmacokineticsPharmacodynamicsDosing GuidelinesAdverse EffectsIndications and PrecautionsPatient Education for Use of Antibacterial MedicationsSummaryCase StudiesPart III. Drugs for Treating Common ConditionsChapter 11. Drugs for Treating Asthma and Other Respiratory ConditionsRespiratory InfectionsAllergic Rhinitis and Other AllergiesAsthmaSummaryCase StudiesChapter 12. Drugs for Treating Cardiovascular ConditionsIschemic Chest Pain: Angina PectorisAtherosclerosis and Coronary Artery DiseaseAcute Coronary SyndromeHypertension and Hypertensive CrisisCardiac ArrhythmiasThromboembolismsSummaryCase StudiesChapter 13. Drugs for Treating Diabetes and Disordered Glucose MetabolismGlucose HomeostasisMetabolic DisordersAntidiabetic Agents for Managing Type 2 Diabetes MellitusInsulin for Managing Type 1 and Type 2 Diabetes MellitusDiabetes Care PlanSummaryCase StudiesChapter 14. Drugs for Treating Digestive DisordersNausea and VomitingDiarrheaConstipationGastroesophageal Reflux DiseaseGastritis and Peptic Ulcer DiseaseGastroenteritisFunctional Bowel Disorders: Inflammatory Bowel DiseaseSupportive Care and General Management of Digestive DisordersSummaryCase StudiesChapter 15. Drugs for Treating Common Musculoskeletal and Neurological ConditionsArticular (Joint) PainMusculotendinous PainNeck and Back PainFibromyalgiaComplex Regional Pain SyndromeHeadache DisordersSummaryCase StudiesChapter 16. Drugs for Treating Dermatological ConditionsProtective Barrier of the SkinPrinciples of Topical Dermatologic PharmacologyBacterial Skin and Soft-Tissue InfectionsFungal Skin InfectionsCandidiasisViral Skin Infections: Herpes Simplex and Molluscum ContagiosumAutoimmune Inflammatory Skin ConditionsSummaryCase StudiesChapter 17. Drugs for Treating Reproductive and Genitourinary ConcernsFamily Planning and ContraceptionShort-Acting Hormonal ContraceptivesLong-Acting Reversible ContraceptionBarrier MethodsEmergency ContraceptionRecommendations for Exercise During PregnancySexually Transmitted InfectionsReproductive and Urogenital ConcernsSummaryCase StudiesChapter 18. Drugs for Treating Mental Health ConditionsMental Health ConditionsBehavioral Health EmergenciesTreatment Options for Mental Health DisordersMood DisordersAnxiety DisordersStressor-Related DisordersSleep or Wakefulness DisordersNeurodevelopmental Disorders: Attention-Deficit/Hyperactivity DisorderEating DisordersSubstance-Related DisordersSummaryCase StudiesChapter 19. Drugs and Supplements to Enhance PerformanceSubstances Banned for CompetitionSupplements for Enhancing Musculoskeletal PerformanceSupplements for Treating Neurological ConditionsSupplements for Treating Skeletal ConditionsManipulation of Approved Medications to Enhance PerformanceSummaryCase StudiesChapter 20. Cannabis and CannabinoidsCannabisCannabinoidsAcute Effects of Cannabis UseChronic Effects of Cannabis UseAdverse Effects of CannabisCannabidiolMedical CannabinoidsResearch on Cannabinoid-Based MedicinesPerformance Effects and Sport RegulationRegulation of Cannabis UseClinical RecommendationsSummaryCase StudiesChapter 21. Drug Testing in SportDrug EducationThe Evolution of Drug Testing in SportSupplement StandardsThe Drug-Testing ProcessTesting for MarijuanaTesting for Anabolic SteroidsMasking AgentsResults of Drug TestingDrug ExemptionsSummaryCase StudiesChapter 22. Medications for SurgeryConcepts of AnesthesiaEffects of General AnesthesiaLevels of SedationStages of AnesthesiaTypes of AnesthesiaCommon Applications of Anesthesia in Sports MedicinePreparation for a Surgical ProcedureRecovery From a Surgical ProcedureAdverse Effects of AnesthesiaSummaryCase Studies

    1 in stock

    £63.00

  • University of Minnesota Press Technopharmacology

    15 in stock

    Book SynopsisExploring networked technologies and bioeconomy and their links to biotechnologies, pharmacology, and pharmaceuticals Being on social media, having pornography or an internet addiction, consciousness hacking, and mundane smartness initiatives are practices embodied in a similar manner to the swallowing of a pill. Such close relations of media technologies to pharmaceuticals and pharmacology is the focus of this book. Technopharmacology is a modest call to expand media theoretical inquiry by attending to the biological, neurological, and pharmacological dimensions of media and centers on emergent affinities between big data and big pharma. Trade Review"Technopharmacology overturns how we think about the relation between media technologies and pharmaceutical agents. The book offers compelling new perspectives on the ways in which the agency of media oscillates between toxin and intoxicant, while drug technologies generate new infrastructures of communication."—Thomas Lamarre, Professor in the Department of Cinema and Media Studies and East Asian Languages and Civilizations, University of Chicago. "Technopharmacology hits a sore but absolutely crucial spot: the relation between the pharmaceutical industry and digital media, the pharmacologization of media and the mediatization of pharmacology. A must-read to find new means of orientation in the chaotic post-pandemic world which Big Pharma and Platform Capital increasingly dominate."—Tiziana Terranova, Professor of Cultural Studies and Digital Media, University of Naples "L'Orientale"

    15 in stock

    £14.39

  • Antibiotics: Challenges, Mechanisms,

    American Society for Microbiology Antibiotics: Challenges, Mechanisms,

    4 in stock

    Book Synopsis

    4 in stock

    £93.56

  • Pharmaceutical Science to Improve the Human

    John Wiley and Sons Ltd Pharmaceutical Science to Improve the Human

    1 in stock

    Book SynopsisThis Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2011 Prix Galien USA awards for achievement in pharmaceutical science. Contributions by GlaxoSmithKline, Amgen, Pfizer, and Janssen Biotech present advances in biotechnology and pharmaceutical agents that combat a range of diseases. NOTE: Annals volume are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632 ACADEMY MEMBERS: Please contact the New york Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Sciences receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

    1 in stock

    £99.00

  • John Wiley & Sons Peripheral Brain for the Pharmacist 202526

    5 in stock

    5 in stock

    £22.79

  • American Pharmacist Association The Handbook of Investigational Drug Service Pharmacy

    3 in stock

    3 in stock

    £90.00

  • American Pharmacists Association The Pharmacist in Public Health: Education,

    Out of stock

    Book SynopsisWritten and edited by pharmacists for pharmacists, The Pharmacist in Public Health: Education, Applications, and Opportunities integrates public health concepts into pharmacy practice and empowers pharmacists and student pharmacists to become involved in public health. The three pharmacist editors and more than 50 contributing authors with backgrounds in pharmacy or public health explore pharmacy’s important role in public health, opportunities and challenges for pharmacists, and the need for student pharmacists’ education and involvement. The 22 peer-reviewed chapters document pharmacists’ current public health efforts and highlight the need for pharmacist involvement and expertise to resolve public health issues locally, nationally, and globally. Thoroughly referenced, containing many examples, figures, and practitioner profiles, the book is a resource for practicing pharmacists, student pharmacists, and other professionals in the public health community. Key Features: Chapters 1 through 4 review pharmacists’ practice and education in public health, provide a history and overview of both professions, and trace pharmacists’ practice in the United States Public Health Service. Chapters 5 through 17 describe pharmacy practice roles in public health and address why pharmacists need to be involved. These chapters feature profiles of public health pharmacists and practical recommendations for furthering pharmacists’ involvement and contributions via ACT (“Actions for Change Today”). Chapters 18 and 19 focus on expanding pharmacists’ role in public health through continuing professional development and interprofessional health initiatives. Chapters 20 through 22 are dedicated to promoting and applying public health topics in student pharmacists’ educational and professional activities. The chapters include examples of students’ community outreach and local and global service initiatives to improve public health.Table of Contents Foreword Preface Contributing Authors Reviewers Section One 1. Pharmacists in Public Health 2. Introduction to the History and Profession of American Pharmacy 3. Pharmacist Perspective on the History and Profession of Public Health 4. Development and Mission of Pharmacy in the U.S. Public Health Service Section Two 5. Medication Therapy Management: Improving Public Health 6. Medication Safety: Improving Public Health 7. Improving Medication Use in Older Adults 8. Health Behavior Theories and Models: Frameworks for Health Promotion and Education Programs 9. Primary Prevention: Pharmacist-Delivered Immunization Services 10. Global Health: Expanding the Sphere of Pharmacists’ Influence 11. Emergency Preparedness and Pharmacist Response 12. Ethical and Legal Issues Pertinent to Public Health Pharmacy 13. Strategies for Identifying Health Disparities and Improving Cultural Competence 14. Strategies for Improving Health Literacy and Patient Outcomes 15. Substance Abuse: Prevention and Intervention 16. Correctional Pharmacy: Prisons and Public Health 17. Rural Health and Telepharmacy: Public Health Challenges and Opportunities Section Three 18. Continuing Professional Development for Pharmacists in Public Health 19. Interprofessional Initiatives for Pharmacists in Public Health Section Four 20. Strategies and Resources for Teaching Public Health

    Out of stock

    £63.00

  • Handbook of Nonprescription Drugs: An Interactive

    American Pharmacists Association Handbook of Nonprescription Drugs: An Interactive

    Out of stock

    Book SynopsisWritten and peer reviewed by experts in practice and academia, the 20th edition of the Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care is an authoritative resource for students and for health care providers who counsel and care for patients undertaking self-treatment—nonprescription drugs, nutritional supplements, medical foods, nondrug and preventive measures, and complementary therapies. Its goal is to develop the knowledge and problem-solving skills needed to assess a patient’s health status and current practice of self-treatment, to determine whether self-care is necessary or appropriate, and, if appropriate, to recommend safe and effective self-care measures. KEY FEATURES: Enhanced content in all chapters from the previous edition with up-to-date information beneficial to all health care providers and students. Updates to the universal objectives to complement the content in the chapters focused on medical disorders. Abstracts for each online chapter providing concise introductory material focused on key features of each chapter. Up-to-date content on nonprescription medications including indications, dosages, interactions, current evidence, medical conditions and prescription to nonprescription reclassifications. Quick-reference tools such as treatment algorithms (including exclusions for self-treatment), drug product tables, patient education sidebars, and product administration illustrations.

    Out of stock

    £186.30

  • Basic Skills in Interpreting Laboratory Data

    American Society of Health-System Pharmacists Basic Skills in Interpreting Laboratory Data

    Book SynopsisThe most popular teaching text on laboratory data for pharmacy students and go-to reference for pharmacists in therapeutic practice.Now in its seventh edition, Basic Skills has been expanded and updated to cover new drugs, research, and therapeutic approaches. Written by 40 established clinicians and pharmacy faculty members and reviewed by additional experts, it is designed to make all information clear and quickly accessible. Minicases provide clinical scenarios for using tests and managing patients, and quickview charts throughout offer clear interpretations of lab results.The indispensable guide to interpreting clinical laboratory data.New to this edition: A new chapter on nutrition support Significant updates to all chapters Expanded chapters on Pharmacogenomics and Cardiology Additional section on Infectious Diseases covering Bacteria, and Fungi, Viruses and Mycobacteria Learning points conclude each chapter and highlight key concepts about the laboratory tests 25 chapters divided into three sections: Basic Concepts and Test Interpretations; System Disorders and Diagnostic Tests; and Tests for Special Populations Complex but critical skills are required for clinical pharmacists to effectively use lab data in screening for or diagnosing diseases and in monitoring the safety and effectiveness of treatment. As the only book of its kind specifically written for pharmacists by pharmacists, Basic Skills makes it easier to make accurate and critical decisions based on laboratory data.

    £116.00

  • American Society of Health-System Pharmacists Extended Stability for Parenteral Drugs

    Out of stock

    Book SynopsisGet the support you need to safely extend dating of parenteral drugs beyond the usual 24-hour limit—minimizing waste, lowering medication costs, and enabling optimal patient administration schedules at alternate infusion sites. The new seventh edition features the inclusion of monographs expanded beyond home infusion to be inclusive of all clinical settings where parenteral drugs are stored or compounded.ASHP’s seventh edition of Extended Stability for Parenteral Drugs, by Michelle C. Simpson, PharmD, BCSCP and Eric G. Schaefer, PharmD, MHSA, covers all aspects of determining stability, including the changing elastomeric landscape and the ongoing variability in stability data.New in this edition:All 196 stability monographs completely updated.Including 37 new monographs.Newly published stability information for parenteral nutrition, oncology, specialty, and COVID medications.An extensive list of medications with temperature excursion data for intact vials.Each monograph contains updated extended drug stability data specific to: container, drug manufacturer, concentration, and diluent.Stability timeframes include standardized temperatures for room, refrigerated, frozen, post thaw, and body temperatures.Inclusion of monographs expanded beyond home infusion to be inclusive of all clinical settings where parenteral drugs are stored or compounded.

    Out of stock

    £184.80

  • AHFS® Drug Information® 2024

    American Society of Health-System Pharmacists AHFS® Drug Information® 2024

    15 in stock

    Book SynopsisAHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.Updates in the new edition:Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines.Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments.Contemporary topics such as new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and more.Expanded content on new and emerging gene therapies.Updates to a variety of vaccine monographs including the pneumococcal, rabies, and respiratory syncytial virus vaccinesExpanded content on off-label uses and long-term clinical data,MedWatch alerts, Standardize4Safety information, REMS data, and focused FDA updates for various medications.New content on over 175 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 190 medications.Trade ReviewThis book succeeds in offering an updated drug compendium of evidence-based drug monographs, meeting the needs of today's healthcare professionals. The reference continues to be trustworthy, relying on the most prestigious and knowledgeable drug experts in the medical field.This reference can be used by any healthcare professional utilizing or prescribing medications in their practice, including physicians, pharmacists, physician assistants, and nurse practitioners. The book is so nicely organized and easily referenced that it can also be used by students in the medical, pharmacy, and nursing fields as well."- Melissa M. Potts, BS, PharmD, Doodys Review Service

    15 in stock

    £365.50

  • Native Intoxicants of North America

    University of Tennessee Press Native Intoxicants of North America

    1 in stock

    Book SynopsisThough scholarship on intoxicants in regions like Asia, Africa, Mesoamerica, and South America is plentiful, Native Intoxicants of North America represents the first foray into a study of prehistoric intoxicants throughout North America specifically. In this study, Sean Rafferty fills significant gaps in existing research with a focus on native cultures of North America and holistic coverage of intoxicants by type. Importantly, Rafferty anchors his investigation in an easily overlooked question: why did early humans use intoxicants in the first place?Rafferty begins by discussing the origins of intoxicants and their role in rituals, medicine, and recreation. Subsequent chapters turn to specific intoxicants-hallucinogens, stimulants, alcohol, and tobacco-making ample use of illustrations across disciplines, weaving a tapestry of culture, ritual, medicine, botany, artifact, and history. All the while, Rafferty explores the societal significance of narcotics, stimulants, and hallucinogens on prehistoric North American cultures.While Native Intoxicants of North America focuses specifically on Native cultures, the author's analysis provides the foundation for a valuable broader discussion: that in a world where few human behaviors are universal, experiencing altered states of consciousness is one that transcends culture and time.

    1 in stock

    £48.75

  • Principles of Pharmacology

    H.W. Wilson Publishing Co. Principles of Pharmacology

    1 in stock

    Book SynopsisThis new resource introduces students and researchers to the fundamentals of pharmacology using easy-to-understand language, to provide a solid background, and help readers develop a deeper understanding and appreciation of this important and evolving subject.Pharmacology is a branch of biology that studies the interaction of drugs and living organisms to better understand how they can affect biochemical function. Today, pharmacologists rely on genetics, molecular biology, and biochemistry in the quest to develop effective, personalized medicine.In over 120 articles arranged in A to Z order, Principles of Pharmacology addresses a variety of topics in this field. Entries related to basic principles and concepts include fields of study related to the topic; an abstract that provides a brief, concrete summary of the topic; key concepts important to a proper understanding of the topic; text that gives an explanation of the background and significance; illustrations that clarify difficult concepts via models, diagrams, and charts; and further reading lists that relate to each entry.

    1 in stock

    £139.40

  • Pharmacology Clear & Simple: A Guide to Drug

    F.A. Davis Company Pharmacology Clear & Simple: A Guide to Drug

    Book SynopsisSave time and money with two books in one + online Q&A! Half pharmacology, half dosage calculations—plus an intensive, yet clear & simple review of basic math + online quizzing!Here’s the must-have knowledge and guidance you need to gain a solid understanding of pharmacology and the safe administration of medications in one text. A body systems approach to pharmacology with a basic math review and a focus on drug classifications prepare you to administer specific drugs in the clinical setting.Now with online Q&A practice in Davis Edge!Purchase a new, print copy of the text and receive a FREE, 3-year subscription to Davis Edge, the online Q&A program with 1,600 questions in all, 800 for Medical Assisting and 800 for Nursing. Davis Edge helps you to create quizzes in the content areas you choose to focus on, build simulated practice exams, and track your progress every step of the way.The Text New! Pronunciations for key terms at the beginning of each chapter New! Word-building and gerontological issues features New! New appendix on intravenous therapy Basic math review helps students learn to perform the calculations necessary to administer medications correctly. Medication administration presented through pharmacology basics, techniques and procedures, supplies, safety and regulations, and prescriptions and label “Master the Essentials” tables cover side effects, precautions, contraindications, and interactions for each classification. Drug classification review tables reinforce need-to-know information in each class. “Fast Tip” boxes offer quick facts and mnemonics. “A Closer Look” boxes examine important information in detail. “Check-up Questions” throughout each chapter promote understanding and help students retain and apply the information. Coverage of specific drugs provides context for learning drug classifications. Critical-thinking exercises encourage students to think beyond the chapter and apply their new knowledge to real-life scenarios. Review questions at the end of each chapter reinforce learning. Davis Edge Online Q&A FREE, 3-year access with purchase of new, print text 800 questions for Medical Assisting and 800 for Nursing “Quiz Builder” lets you select practice questions by exam section or topic area. Rationales for correct and incorrect responses provide immediate feedback. “Student Success Center” dashboard monitors your performance over time, helping to identify areas for additional study. Table of Contents Unit 1 Introduction to Pharmacology 1. History of Pharmacology 2. Basics of Pharmacology 3. Patient Safety in Medication Administration 4. Regulations 5. Prescriptions and Labels Unit 2 Calculations 6. Review of Mathematics 7. Measurement Systems 8. Dosage Calculations Unit 3 Administration of Medications 9. Enteral Medications and Administration 10. Parenteral Medications and Administration Unit 4 Classifications of Drugs 11. Integumentary System Medications 12. Musculoskeletal System Medications 13. Nervous System Medications 14. Eye and Ear Medications 15. Endocrine System Medications 16. Cardiovascular System Medications 17. Immunological System Medications 18. Pulmonary System Medications 19. Gastrointestinal System Medications 20. Reproductive and Urinary System Medications 21. Vitamins, Minerals, Herbs, and Complementary and Alternative Medicine Glossary Appendix A Drug Classifications Appendix B Drug Classification index by Generic Name Appendix C Controlled Substances Schedules Appendix D Routine Pediatric and Adult Immunizations Appendix E Administering Medications to Children Appendix F Pediatric Drug Calculations Appendix G Examples of Herbs, Vitamins, Minerals, Amino Acids, and Lipids Used as remedies Appendix H Basic Math Concepts Appendix I Answers to Check Ups Appendix J IV therapy

    £69.30

  • Pharmacology in Rehabilitation

    F.A. Davis Company Pharmacology in Rehabilitation

    Book SynopsisUp-to-date, must-know coverageBring your understanding of the rapidly evolving world of pharmacological agents and their impact on rehabilitation up to date with the Updated 5th Edition of this groundbreaking reference. An easy-to-understand writing style and easy-to-follow design help you to understand the what, why, and how of this complex subject to ensure the most effective plans of care for your patients.Table of Contents Unit 1. General Principles of Pharmacology 1. Basic Principles of Pharmacology 2. Pharmacokinetics I: Drug Administration, Absorption, and Distribution 3. Pharmacokinetics II: Drug Elimination 4. Drug Receptors Unit 2. Pharmacology of the Central Nervous System 5. General Principles: Central Nervous System Pharmacology 6. Sedative-Hypnotic and Antianxiety Agents 7. Drugs Used to Treat Affective Disorders: Depression and Bipolar Syndrome 8. Antipsychotic Drugs 9. Antiepileptic Drugs 10. Pharmacologic Management of Parkinson Disease 11. General Anesthetics 12. Local Anesthetics Unit 3. Drugs Affecting Skeletal Muscle 13. Skeletal Muscle Relaxants Unit 4. Drugs Used to Treat Pain and Inflammation 14. Opioid Analgesics 15. Nonsteroidal Anti-Inflammatory Drugs 16. Pharmacologic Management of Rheumatoid Arthritis and Osteoarthritis 17. Patient-Controlled Analgesia Unit 5. Autonomic and Cardiovascular Pharmacology 18. Introduction to Autonomic Pharmacology 19. Cholinergic Drugs 20. Adrenergic Drugs 21. Antihypertensive Drugs 22. Treatment of Angina Pectoris 23. Treatment of Cardiac Arrhythmias 24. Treatment of Congestive Heart Failure 25. Treatment of Coagulation Disorders and Hyperlipidemia Unit 5. Respiratory and Gastrointestinal Pharmacology 26. Respiratory Drugs 27. Gastrointestinal Drugs Unit 6. Endocrine Pharmacology 28. Introduction to Endocrine Pharmacology 29. Adrenocorticosteroids 30. Male and Female Hormones 31. Thyroid and Parathyroid Drugs: Agents Affecting Bone Mineralization 32. Pancreatic Hormones and the Treatment of Diabetes Mellitus Unit 7. Chemotherapy of Infectious and Neoplastic Diseases 33. Treatment of Infections I: Antibacterial Drugs 34. Treatment of Infections II: Antiviral Drugs 35. Treatment of Infections III: Antifungal and Antiparasitic Drugs 36. Cancer Chemotherapy 37. Immunomodulating Agents 38. Complimentary and Alternative Medications Appendices: Drugs Administered by Iontophoresis and Phonophoresis/Use of the Physician’s Desk Reference/Drugs of Abuse

    £72.90

  • Natural Polymers for Drug Delivery

    CABI Publishing Natural Polymers for Drug Delivery

    7 in stock

    Book SynopsisNatural polymers have been utilized extensively in food, pharmaceuticals, cosmetics, textiles, oil drilling and paint industries. Their non-toxic and inexpensive attributes readily enhance their commercial acceptability and make them potent agents in lieu of synthetic polymers. This book explores the opportunistic utility of natural polymers in developing effective drug delivery systems and provides a comprehensive and up-to-date analysis of their source, chemical structure and mechanism of action. Covering novel polymers for drug delivery - in particular extracts from plants, microorganisms and proteins, as well as water soluble and water insoluble biodegradable polymers - it presents an encyclopaedic overview of natural polymers': - quintessential roles in binding drugs towards enhancing bioavailability - modification and derivatization for targeted delivery - role as active drugs Natural Polymers for Drug Delivery is an invaluable resource for researchers, students and industrial scientists in the fields of biochemistry, chemistry, pharmacology and food science.Table of Contents1: Natural Polymers for Drug Delivery: An Introduction Section I: Drug Delivery Based on Different Classes of Polymers 2: Cellulose-based Polymeric Systems in Drug Delivery 3: Hydrocolloids-based Hydrogels in Drug Delivery 4: Water Soluble Biodegradable Polymers for Drug Delivery 5: Polysaccharide-based Drug Carriers 6: Polymer-based Nanoparticles for Drug Delivery Systems and Cancer Therapeutics 7: Polymer Nanocomposite-based Biosensors for Drug Delivery Applications Section II: Polymeric Interaction and Conjugates 8: Polymer-Drug Conjugates: Targeted Drug Delivery 9: Protein-Drug Conjugates: A New Class of Biotherapeutics 10: Microencapsulation for Controlled Gastrointestinal Delivery of Probiotics and Prebiotics Section III: Disease-specific Drug Delivery Systems 11: Chitosan in Drug Delivery and Targeting for Cancer Treatment 12: Polymers as Biodegradable Matrices in Transdermal Drug Delivery 13: Ocular Drug Delivery Systems 14: Natural Polymers Targeting Habitual Disease 15: Bioengineered Wound and Burn Healing Substitutes: Novel Design for Biomedical and General Applications

    7 in stock

    £99.76

  • Leafy Medicinal Herbs: Botany, Chemistry,

    CABI Publishing Leafy Medicinal Herbs: Botany, Chemistry,

    Book SynopsisMedicinal herbs are rich in vitamins, minerals and antioxidants, and are able to synthesize secondary metabolites with disease preventive properties. It is due to these qualities that herbs have been used throughout history for flavouring and in food, medicine and perfumery preparations. They are also often considered to be safe alternatives to modern medicines because of their healing properties. Though interest in medicinal and aromatic crops is growing worldwide, there is still little focus on the area of leafy medicinal herbs. This book compiles the literature for 23 globally relevant leafy medicinal herbs. Beginning with a general overview and discussion of the importance of these plants, it then handles each herb by chapter. Chapters discuss the botany of the crop, including its history and origin, geographical distribution and morphology, before focusing on the chemical composition and phytochemical attributes. They then review postharvest technology aspects such as processing and value addition, before concluding with the general and pharmacological uses for each crop. A complete compilation of the subject, this book forms a vital resource for researchers, students, farmers and industrialists in the area of leafy medicinal herbs.Table of Contents:: Introduction :: Preface 1: Aloe Vera 2: Ashwagandha 3: Basil 4: Bay Leaf 5: Betel Vine 6: Celery 7: Centella 8: Chester 9: Coriander 10: Curry Leaf Plant 11: Fenugreek 12: Lemongrass 13: Mint 14: Moringa 15: Oregano 16: Parsley 17: Patchouli 18: Rosemary 19: Sage 20: Senna 21: Spinach 22: Stevia 23: Thyme

    £99.76

  • Antimicrobial Peptides: Discovery, Design and

    CABI Publishing Antimicrobial Peptides: Discovery, Design and

    7 in stock

    Book SynopsisAntimicrobial peptides (AMPs) have attracted extensive research attention worldwide. Harnessing and creating AMPs synthetically has the potential to help overcome increasing antibiotic resistance in many pathogens. This new edition lays the foundations for studying AMPs, including a discovery timeline, terminology, nomenclature and classifications. It covers current advances in AMP research and examines state-of-the-art technologies such as bioinformatics, combinatorial libraries, high-throughput screening, database-guided identification, genomics and proteomics-based prediction, and structure-based design of AMPs. Thoroughly updated and revised, this second edition contains new content covering: defensins; cathelicidins; anti-MRSA, antifungal, antiviral, anticancer and antibiofilm strategies; combined treatments; adjuvants in vaccines; advances in AMP technologies that cover surface coating to prevent biofilm formation; nanofiber encapsulation technologies for delivery and sustained release; and understanding innate immunity and the basis for immune boosting to overcome obstacles in developing AMPs into therapeutic agents. Written and reviewed by a group of established investigators in the field, Antimicrobial Peptides is a valuable resource for postgraduate students, researchers, educators, and medical and industrial personnel.Table of ContentsPART I: OVERVIEW OF ANTIMICROBIAL PEPTIDES 1: Discovery, Classification and Functional Diversity of Antimicrobial Peptides PART II: NATURAL TEMPLATES FOR PEPTIDE ENGINEERING 2: Structural and Functional Diversity of Cathelicidins 3: Disulfide-linked Defensins and Their Therapeutic Potential 4: Lantibiotics: Bioengineering and Applications PART III: EXPANDING PEPTIDE SPACE: COMBINATORIAL LIBRARY, GENOME-BASED PREDICTION AND DE NOVO DESIGN 5: Discovery of Novel Antimicrobial Peptides Using Combinatorial Chemistry and High-throughput Screening 6: Prediction and Design of Antimicrobial Peptides: Methods and Applications to Genomes and Proteomes PART IV: MECHANISMS OF ACTION: BIOPHYSICS AND STRUCTURAL BIOLOGY 7: Antimicrobial Peptides: Multiple Mechanisms Against a Variety of Targets 8: Microbial Membranes and the Action of Antimicrobial Peptides 9: Non-membranolytic Mechanisms of Action of Antimicrobial Peptides – Novel Therapeutic Opportunities? 10: Structural Insight into the Mechanisms of Action of Antimicrobial Peptides and Structure-based Design PART V: NOVEL THERAPEUTIC STRATEGIES: SYNERGY, IMMUNE MODULATION, SURFACE COATING, AND DELIVERY 11: Synergy of Antimicrobial Peptides 12: Surface Immobilization of Antimicrobial Peptides to Prevent Biofilm Formation 13: Sustained Delivery of Cathelicidin Antimicrobial Peptide-Inducing Compounds to Minimize Infection and Enhance Wound Healing 14: Immunomodulatory Activities of Cationic Host Defence Peptides and Novel Therapeutic Strategies

    7 in stock

    £106.70

  • Botanical Medicine in Clinical Practice

    CABI Publishing Botanical Medicine in Clinical Practice

    Book SynopsisThe potential benefits of plants and plant extracts in the treatment and possible prevention of many leading health concerns are becoming more widely recognised within the medicinal community. This major comprehensive reference work contains contributions from more than 80 clinical and academic experts in the field, covering a range of plant products and their uses, divided into sections on topics such as treatments of cardiovascular diseases and cancer. The book covers the safety and efficacy of botanical treatments and there is also a chapter analysing the possible interactions of herbal remedies with prescription drugs. This is the most up-to-date text on the latest research findings from all over the world and will be an essential resource.Table of Contents1: Herbal Remedies with Geographical Historical Uses 2: Infectious Diseases Treatment and Immunomodulation 3: Treatment of Disorders 4: Cancer Prevention and Treatment 5: Cardiovascular Therapy 6: Diabetes 7: Therapy of Chronic Diseases 8: Botanicals and their extracts in Health Promotion 9: Interactions with other Medicines

    £262.12

  • Antimicrobial Drug Discovery: Emerging Strategies

    CABI Publishing Antimicrobial Drug Discovery: Emerging Strategies

    3 in stock

    Book SynopsisDrug resistance is increasing among a variety of human pathogenic microorganisms such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumaniii, Pseudomonas aeruginosa and Enterobacter spp. (currently dubbed the 'ESKAPE' pathogens), and has emerged as one of the most important clinical challenges of this century. Increased general awareness and fear of these pathogens means there is a growing demand for research to tackle the threat of multidrug resistance. Documenting the latest research in the field, this book discusses current and promising activities to discover new antimicrobials in five key areas: molecular genetics and systems microbiology; synthetic, computational chemistry and chemoinformatics; High Throughput Screening (HTS); non-vertebrate model hosts; and light- and nano-based technologies.Table of Contents1: Emerging Antimicrobial Drug-discovery Strategies: an Evolving Necessity 2: The Antibiotic Crisis 3: Structure, Genetic Regulation, Physiology and Function of the AcrAB-TolC Efflux Pump of Escherichia coli and Salmonella 4: Small-molecule Efflux Pump Inhibitors from Natural Products as a Potential Source of Antimicrobial Agents 5: Fungal Efflux-mediated Resistance: from Targets to Inhibitors 6: Vacuolar ATPase: a Model Proton Pump for Antifungal Drug Discovery 7: Drug Tolerance, Persister Cells and Drug Discovery 8: Inhibition of Quorum Sensing as a Novel Antimicrobial Strategy 9: Filamentous Temperature-sensitive Mutant Z (FtsZ) Protein as an Antibacterial Target 10: Lysostaphin: a Silver Bullet for Staph 11: Strategies to Identify Modified Ribosomally Synthesized Antimicrobials 12: Quantitative Structure-Activity Relationship-based Discovery of Antimicrobial Peptides Active Against Multidrug-resistant Bacteria 13: Acetyl-CoA Carboxylase as a Target for Antibacterial Development 14: Underexploited Targets in Lipopolysaccharide Biogenesis for the Design of Antibacterials 15: Predicting and Dissecting High-order Molecular Complexity by Information-driven Biomolecular Docking 16: Antifungals and Antifungal Drug Discovery 17: Pathosystematic Studies and the Rational Design of Antifungal Interventions 18: In Vivo High-throughput Antimicrobial Discovery Screens Utilizing Caenorhabditis elegans as an Alternative Host 19: Drosophila melanogaster as a Versatile Model for the Discovery of Drugs Effective against Human Microbe-induced Infection and Pathology 20: Antimicrobial Photosensitizers: Harnessing the Power of Light to Treat Infections 21: Nanoparticle Platforms for Antimicrobial Therapy 22: Antimicrobial Activity of Carbon Nanotubes

    3 in stock

    £131.26

  • Anthony Cerami: A Life in Translational Medicine

    Rutgers University Press Anthony Cerami: A Life in Translational Medicine

    1 in stock

    Book SynopsisSince the turn of the new millennium, ‘translational research’, the scientific process of bringing disease-targeted knowledge from the laboratory to treat patients in the clinic, has gone mainstream and is now practiced by large universities and institutes across the globe. Into this dynamic of the rapidly changing world of translational medical research this book sets the life of one of the discipline’s most influential practitioners, Anthony Cerami. His work spans more than five decades and culminated in the discovery, invention and development of diagnostics and therapeutics used daily by millions of people. Students in molecular medicine and investigators pursuing basic science in the hope of improving human health will find inspiration in examining the sacrifices and achievements of Cerami’s career in translational medicine. During his three decades at Rockefeller University his cross-disciplinary and laboratory-without-wall approach established ‘rational drug design’ as the most effective means of advancing the fields of parasitology, hematology, immunology, metabolism, therapeutics and molecular medicine. Cerami’s story and that of the evolution of translation are intimately entwined: the contours of Cerami’s career shaped by developments in translation, and in exchange, the field itself molded by Cerami’s work. To understand one is to understand the other. By examining the life of this often overlooked biochemist it is possible to intimately focus on the ideas and thought processes of a scientist who has helped to define the great acceleration in translational research over the past half century – research that, knowingly or otherwise, has most likely affected the life of almost everyone on the planet. We also gain a better understanding of the febrile creative atmosphere that percolated through the laboratories leading the way in translational medicine, and gain insight into the art, science, successes, failures and providence that underlie major scientific breakthroughs. Anybody interested in the questions of where modern medicines come from, how health outcomes around the globe are affected by research and imagination, and where the future of drug discovery is leading, will be rewarded by exploring Cerami’s life in translation. This book is not restricted to those with a professional interest in science, because anyone dedicated to living a life of creativity and discovery will be rewarded by reading this book. In many respects, Cerami’s life reflects the modern metaphor of the ‘American dream’ with his journey from humble beginnings on a chicken farm in rural New Jersey, to occupying a place in the highest echelons of the US scientific establishment. His journey in translational medicine was propelled forward by two obsessions; the idea that he could help people who were sick, and the excitement of discovery. In following his two great passions, he trained a generation of specialists in translational medicine that continue to transform our understanding of, and treatments for, human disease. Anthony Cerami’s work has shown how science has become an important force for social change by laying the foundations of modern translational medicine. Trade Review“Tony Cerami has been one of the most creative exponents of translational medicine. He has combined innovative science with novel approaches to experimental medicine to better understand the basis of disease and how therapies work and his insights into diseases such as sleeping sickness and diabetes have had a wide impact on medicine.” -- Sir John Bell * Regius Chair of Medicine at the University of Oxford *“Translation of scientific discoveries into useful applications is central to modern biomedicine, leading to the development of new and more effective ways of treating human disease. Anthony Cerami has played a critical role in establishing and promoting translation through a half-century career in laboratory research aimed at new methodologies and rational drug design for improved diagnosis and therapies. Read this book to follow his life from a chicken farm to respected biomedical scientist, and to learn how translation has evolved in recent decades and has brought benefit to humankind through better treatment of disease.” -- Sir Paul Nurse * Director of the Francis Crick Institute *"This is a fascinating profile of a remarkable man who throughout his life has made key contributions to the warp and the weft of translational medicine. His work on cachectin/TNF alone has had a huge impact, contributing both to transformational treatments for inflammatory diseases and to the reshaping of the pharmaceutical industry.” -- Sir Greg Winter * Trinity College Cambridge *“Tony Cerami is one of the great unsung heroes of biomedical research. His discoveries had a direct impact on the development of cytokine inhibitors as a strategy to treat inflammatory diseases. Conrad Keating has done a great job in telling Tony’s story and conveying his huge contribution to translational medicine.” -- Luke O'Neill * Trinity College Dublin *"A 'smooth' read that describe[s] [Anthony Cerami's] scientific successes as well as his scientific and personal failures. After reading this book, it is clear to me that most scientists would do well to emulate the successes of Dr. Cerami but to also avoid his failures. Nonetheless, as clearly covered in this book, his career was exciting and constantly challenging....This will make a good summer beach read." -- Howard Young, Ph.D., * Past President International Society of Interferon and Cytokine Research *Table of ContentsForeword Introduction 1. Hard Work 2. The Rockefeller Effect 3. The Shaping of a Scientific Mind 4. The Rockefeller University and the Broad Horizon 5. Diabetes: The Creation of the Hemoglobin A1c Test 6. Glucose, Aging, and the Cross-linking of Biology and Business 7. The Conceptual Breakthrough 8. Cachectin—Tumour Necrosis Factor 9. Leaving The Rockefeller University: The End of the Dream 10. Philanthropy Goes Awry 11. Translation in Transition 12. Anti-TNF Therapy: Changing the Pharmaceutical Landscape 13. Taking on Big Pharma Acknowledgments Notes Index

    1 in stock

    £34.20

  • Principles of Forensic Toxicology

    Springer Nature Switzerland AG Principles of Forensic Toxicology

    Book SynopsisThe fifth edition of the best-selling Principles in Forensic Toxicology continues in the tradition of excellence in academic publishing. With over 10 years of classroom-tested and continually updated content, the new edition contains significant updates and 7 new chapters on new topics including drug-facilitated crimes, derivatization, quantitation, measurement uncertainty/traceability, statistics, oral fluid testing, and drugs in embalmed specimens. Part One covers the major sub-disciplines of forensic toxicology in addition to pharmacological concepts. Part Two addresses specimen preparation, laboratory testing and instrumental analysis, while Part Three discusses common analytes including cocaine, opioids, alcohol, and marijuana. Adopted for courses in many of the top universities for forensic science and used by respected medical examiner’s offices and crime laboratories worldwide, Principles of Forensic Toxicology prepares the next generation of forensic toxicologists and continues to be an important reference in professional practice.Table of ContentsPart 1: Introduction.- Post Mortem Forensic Toxicology.- Human Performance Toxicology.- Drug-Facilitated Sexual Assault.- Forensic Drug Testing.- Performance enhancing Drug Testing.- Drug Testing in Pain Management.- Pharmacokinetics and Pharmacodynamics.- Part II. Specimen Preparation.- Spectrophotometry.- Chromatography.- Derivatization.- Immunoassy.- Mass Spectrometry.- Quantitation.- Method Validation.- Measurement Uncertainty and Traceability.- Statistics in Forensic Toxicology.- Part III Analytes.- Alcohol.- Benzodiazapines.- Gammahydroxybutyric acid,- Miscellaneous Central Nervous System Depressants.- Opioids.- Cocanie.- Cannabis.- Amphetamines-Sympathomimetic Amines,- Hallucinogens and Psychedelics.- Antidepressants and Neuroleptics.- Miscellaneous Therapeutic Drugs.- Carbon Monoxide/Cyanide.- Inhalants.- Metals.- Part III Special Topics.- Stability of Drugs of Abuse in Biological Systems.- Postmortem Redistribution of Drugs.- Postmortem Clinical Testing.- Pharmacogenomics.- Hair Drug Testing.- Oral Fluid Testing.- Meconium Drug Testing.- Drugs in Embalmed Tissues.

    £61.74

  • Outbreak in the Village: A Family Doctor's

    Springer Nature Switzerland AG Outbreak in the Village: A Family Doctor's

    3 in stock

    Book SynopsisOutbreak in the Village is a fascinating account of the personal and professional journey of Dr. Doug Jenkinson, physician and researcher. Over the course of four decades in practice, Jenkinson traces the reemergence of whooping cough in the developed world, using his practice in the idyllic English countryside as a clinical control group. Keeping meticulous notes and indulging an itch to investigate, he explores one of history's most enigmatic and pervasive diseases. Jenkinson relates the tale of his life's work amid winsome anecdotes, relevant history, and practical advice. Told in an amiable, engaging voice with an expert balance of levity and earnestness, this story will charm casual readers interested in medical history and memoir, as well as doctors and researchers who identify with the experiences and may benefit from the research and techniques employed. Readers will find themselves in the examination room beside Jenkinson as the investigation unfolds, learning about the nature of the illness and the sweeping detrimental effects of an anti-vaccination campaign. An intriguing memoir about a mysterious illness, a public health failure, and one doctor's quest for clarity, Outbreak in the Village is a tale of perseverance and objectivity sure to delight and inform.Table of Contents Introduction From Africa to England The children’s clinic at Keyworth Whooping cough vaccine 1977–9. The first outbreak of whooping cough Does the vaccine work? 1981. Whooping cough vaccine is very rarely harmful 1981–3. The second outbreak. How many cases are there really? 1985–7. The third outbreak. The search for subclinical infection 1987. Does the effectiveness of the vaccine wear off? 1988. Trying to raise the uptake of pertussis vaccine 1989–91. The fourth outbreak. The natural history of whooping cough 1990s. Whooping cough fades away but new diagnostic tests emerge 2000. Whoopingcough.net. Overcoming diagnostic paralysis The early noughties. The new tests aid the re-discovery of whooping cough Late noughties. ‘Resurgence’ of whooping cough in the USA and Australia puts the UK on alert 2012. Whooping cough diagnoses peak in the UK but remain unchanged in Keyworth What lies ahead? Epilogue About Bordetella bacteriaAge incidence changes in Keyworth whooping cough patients A critical look at recent pertussis statistics in England

    3 in stock

    £22.49

  • Toxicology of Organophosphate Poisoning: New

    Springer Nature Switzerland AG Toxicology of Organophosphate Poisoning: New

    5 in stock

    Book SynopsisThis book addresses the consequences of high agricultural pesticide use over the last few decades in the form of organophosphate poisoning. The authors provide a background overview of organophosphate compounds, their environmental toxicity, non-target exposures and cases of human poisoning. The authors also compile and analyze data from the last two decades to demonstrate the toxicological aspects of organophosphates, and how they can pose a threat to human health. Readers will learn about the clinical manifestation of organophosphate exposure in humans, as well as the enzymatic pathways and mechanisms by which organophosphates are processed in the body and cause harm. The book concludes by providing techniques, practices and recommendations for how to manage organophosphate exposure and poisoning. It will be useful for clinicians and public health professionals, scientists, medical practitioners, researchers and environmental toxicologists. Table of ContentsChapter 1: Overview of organophosphate compounds.- Chapter 2: Toxicology of Organophosphate poisoning in humans.- Chapter 3: Enzymatic Targets of organophosphates.- Chapter 4: Computational insights of human acetylcholinesterase inhibition.- Chapter 5: New insights in Prophylactic approaches of human poisoning.- Chapter 6: Management of human Organophosphate poisoning.- Chapter 7: Summary.

    5 in stock

    £104.49

  • Gene and Cellular Immunotherapy for Cancer

    Springer Nature Switzerland AG Gene and Cellular Immunotherapy for Cancer

    Book SynopsisClinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL). These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia. Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies. Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more. Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by a diverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field.Table of ContentsPart I: Overview1. The History of Cellular Therapies 2. Basics of Immunity Part II: CAR-T3. Biology of CAR-T 4. Cell Types Used for CAR-T Generation5. Combination Therapeutics with CAR-T Cell Therapy 6. Safety Switches Used for Cellular Therapies7. Off the Shelf CAR-T8. Manufacturing of CAR-T Cells: the Assembly Line9. Navigating Regulations in Gene and Cell Immunotherapy10. Bringing CAR-T to the Clinic11. CAR-T Cell Complications 12. Mechanisms of Resistance and Relapse after CAR-T Cell Therapy Part III: TIL13. Tumor Infiltrating Lymphocytes (TIL): From Bench to Bedside Part IV: TCR14. T-cell Receptor (TCR) Engineered Cells and Their Transition to Clinic Part V: Viral CTLs15. Viral Cytotoxic T Lymphocytes (CTLs): from Bench to BedsidePart VI: NK Cell16. Biology of NK Cells and NK Cells in Clinic Part VII: T/NK cell engagers17. Biology and Clinical Evaluation of T/NK Cell Engagers Part VIII: Logistics 18. Roadmap for Starting an Outpatient Cellular Therapy Program

    £116.99

  • Formulating Poorly Water Soluble Drugs

    Springer Nature Switzerland AG Formulating Poorly Water Soluble Drugs

    3 in stock

    Book SynopsisThe objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist’s approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound’s physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.Table of ContentsContents 1. Route-Specific Challenges in the Delivery of Poorly Water-Soluble Drugs ……………….. Zachary Warnken, Hugh D.C. Smyth, and Robert O. Williams III 2. Optimizing the Formulation of Poorly Water-Soluble Drugs………………………….. Xiangyu Ma, Daniel Ellenberger, Kevin P. O’Donnell, and Robert O. Williams III 3. Solid-State Techniques for Improving Solubility ……………………………………….. Miguel O. Jara, Justin R. Hughey, Siyuan Huang, and Robert O. Williams III 4. Mechanical Particle-Size Reduction Techniques…………………………..……….…… Javier O. Morales, Alan B. Watts, and Jason T. McConville 5. Co-solvent and Complexation Systems …………………………………………….... Junhuang Jiang and Robert O. Williams III 6. Injectable Formulations of Poorly Water-Soluble Drugs ………………………….…... Hannah L. O’Mary and Zhengrong Cui, 7. Lipid-Based Formulations…………………………………………………................... Daniel A. Davis Jr., Han-Hsuan Peng, and Robert O. Williams III 8. Structured Development Approach for Amorphous Systems ……………………….... Susanne Page, Reto Maurer, Nicole Wyttenbach, and Felix Ditzinger 9. Melt Extrusion………………………………………………………………………. Stephen A. Thompson, Daniel A. Davis Jr., James C. DiNunzio, Charlie Martin, Robert O. Williams III, and Feng Zhang 10. Spray-Drying Technology…………..………..………..………..……………………….. Dave A. Miller, Daniel Ellenberger, Tiago Porfirio, and Marco Gil 11. Pharmaceutical Cryogenic Technologies ………………………………………….... Sawittree Sahakijpijarn, Chaeho Moon, and Robert O. Williams III 12. Precipitation Technologies for Nanoparticle Production ……………………………. Tuangrat Praphawatvet and Robert O. Williams III 13. Emerging Technologies to Increase the Bioavailability of Poorly Water-Soluble Drugs … Daniel A. Davis Jr., Rishi Thakkar, Mohammed Maniruzzaman, Dave A. Miller, Robert O. Williams III 14. Scientific and Regulatory Considerations for Development and Commercialization of Poorly Water-Soluble Drugs…………………………………………………………………. .Zedong Dong and Hasmukh Patel

    3 in stock

    £189.99

  • The Kappa Opioid Receptor

    Springer Nature Switzerland AG The Kappa Opioid Receptor

    3 in stock

    Book SynopsisThis book covers the latest knowledge in structure, signaling, and biochemical pharmacology of KOR as well as preclinical research and clinical applications (including clinical phase studies and approved for human use) of KOR compounds. It is divided up into the three parts: Molecular aspects of KOR, Preclinical research on pharmacology of KOR agonists and antagonists in animals and KOR agonists and antagonists in clinical use and in past and present clinical trials.The chapters "Biosensors monitor ligand-selective effects at kappa opioid receptors" and "The role of dynorphin and the kappa opioid receptor in schizophrenia and major depressive disorder: a translational approach" of this book are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.Table of Contents

    3 in stock

    £107.99

  • Springer Nature Switzerland AG Pharmacological Treatment of Alzheimer's Disease:

    Out of stock

    Book SynopsisAlzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years.This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers.In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer’s disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer’s disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer’s disease.Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.Table of Contents1. IntroductionGustavo Alves Andrade dos Santos 2. Principles of Pharmacology in DementiaFrancisco Assis Carvalho Vale, Judith Thomas Tayra, Carina Tellaroli Spedo3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's DiseaseFabricio Ferreira de Oliveira4. The Use of Esterase InhibitorsGustavo Alves Andrade dos Santos, Carolina Witchmichen Penteado Schmidt, Karina Pedrotti Forlenza5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s DiseaseCarolina Witchmichen Penteado Schmidt 6. Supportive Pharmacological TreatmentKaléu Mormino Otoni, Karla Bruna Nogueira Torres Mormino, Sandna Larissa Freitas dos Santos, Maria Liliane Luciano Pereira7. Herbal Medicines and SupplementsEduardo Caritá 8. Emergency SituationsMilena Carvalho Libardi, GuilhermeRiccioppo Rodrigues, Rui Kleber Martins Filho9. Relationships between Treatment and Clinical EvaluationsPaulo Pardi, Gustavo Alves Andrade dos Santos10. New Perspectives for Treatment in Alzheimer's DiseaseJúlia Cunha Loureiro, Marcos Vasconcelos Pais, Luiz Fernando de Almeida Lima e Silva, Orestes Vicente Forlenza

    Out of stock

    £999.99

  • Deuterium Oxide and Deuteration in Biosciences

    Springer International Publishing AG Deuterium Oxide and Deuteration in Biosciences

    1 in stock

    Book SynopsisThis new book provides comprehensive coverage of the subjects of deuterium oxide and deuteration in biosciences, with an emphasis on the biochemical, biomedical, and pharmacological aspects. Deuterium oxide and deuteration effects also offer various implications for health-related issues, including diseases, vaccines and drugs. Organized in six sections, the chapter topics include the role of regular and heavy water in biosciences, and their implications to biomolecules, biochemical processes, health-related research, and pharmacology. Due to the broad scope, the book may be used as a supplemental text for upper-level undergraduate and graduate courses in the related fields of biochemistry, biology, biomedical sciences, biophysics, and pharmacology. Researchers and pharmaceutical industry professionals will also find the content useful in order to gain knowledge and better understand the implications of deuterium oxide and deuteration research.Table of ContentsSection I. Roles of regular and heavy water in biosciences Overview: background and applications Characteristics of deuterium oxide versus hydrogen oxide Section II. Molecular interactions of deuterium versus hydrogen oxide Deuterium bonding versus hydrogen bonding Hydrophobic interaction in D2O versus H2O Section III. Implications of deuterium oxide and deuteration in biological Systems Deuterium oxide and deuteration effects on biomolecules Effects of D2O and deuteration on biomembranes Section IV. Applications of D2O and deuteration to biochemical reactions Biochemical effects of deuterium oxide and deuteration Physical methods for investigating D2O and deuteration effects Section V. Exploration of deuterium oxide and deuteration in health-related research Living cells grown in deuterium oxide and deuteration Deuterium oxide and deuteration effects on health issues Section VI. Applications of deuterium oxide and deuteration to pharmacology Deuterium oxide effects on thermostability of vaccines Deuterium oxide and deuteration effects on pharmacology

    1 in stock

    £104.49

  • New Discoveries in the Behavioral Neuroscience of

    Springer International Publishing AG New Discoveries in the Behavioral Neuroscience of

    3 in stock

    Book SynopsisNew Discoveries in the Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder reviews the latest developments in preclinical and clinical research of Attention Deficit Hyperactivity Disorder. As well as updating key chapters that were included in an earlier edition, this volume includes some new topics that are attracting a great deal of interest and point the way to new and promising directions for future research. The chapters follow five main themes: Current perspectives on the clinical profile of ADHD and its treatment, common co-occurring conditions, neurobiological studies examining brain function and genetics, animal and in vitro studies, and future directions. This combination of topics emphasises the translational relevance and validity of preclinical research so as to enable a better understanding of ADHD and to highlight the promising strategies for developing new treatments.Table of ContentsCLINICAL PROFILE AND TREATMENTS.- ADHD in children and adults: diagnosis and prognosis.- Treatment strategies.- Psychostimulants – treatment efficacy and problems.- Recent developments and future options for pharmacological treatments for ADHD.- GENETICS.- Genetics of ADHD (including CNVs).- Genes , cognitive function and ADHD.- Epigenetics and ADHD.- CO-MORBIDITY.- ADHD and comorbid depression.- ADHD and autism.- Aggression and ADHD.- Obesity and ADHD (+ cytokines?).- Sleep circadian rhythms and ADHD.- Substance misuse .- ASSESSING BRAIN FUNCTION / DYSFUNCTION.- EEG and ADHD (the skeptical view).- Update on imaging – with connectivity.- Visual processing substrates for ADHD.- Cortical microstructure / connectivity.- ANIMAL AND IN VITRO STUDIES.- Critique of animal models.- Update on circuits for impulsive behaviour.- Zebrafish.- Update on DA transporter and ADHD.- Arousal, noradrenaline and ADHD.- FUTURE DIRECTIONS.- Stem cells for disease modelling.- Microbiome and ADHD.- Adult ADHD.

    3 in stock

    £116.20

  • Technology for Drug Safety: Current Status and Future Developments

    Springer International Publishing AG Technology for Drug Safety: Current Status and Future Developments

    1 in stock

    Book SynopsisThis book presents information about the use of technology to support the prevention and management of drug safety issues: pharmacovigilance (PV), medication errors, drug-related problems (DRPs), counterfeit medicines and other drug safety issues. Adapting new technologies/information technologies, mobile technologies and social media has contributed effectively to safety practices for medications, with this book providing comprehensive information as a guide to its challenges and potential. Technology for Drug Safety provides practicing and trainee pharmacists, pharmacy technicians, pharmacy educators, researchers, public health policy makers, healthcare professionals and medical educators with vital information about the impact of technology on drug safety-related issues. It describes the current status of the practice, the challenges in the field and recommendations for the effective use of technology in drug safety practice including clinical trials and drug development, PV, detection of adverse drug reactions, reporting and management, medication errors detection, reporting and management, DRPs, counterfeit and substandard medications, and other safety issues.Table of ContentsImportance of Technology for Drug Safety .- History of Drug Safety and Technology for Drug Safety.- Electronic Registration and Medical Records for Drug Safety.- Electronic Prescriptions and orders for Drug Safety.- Computer Technologies for Drug Safety.- Internet Technologies for Drug Safety.- Artificial intelligence & Machine Learning for Drug Safety.- Mobile technologies for Drug Safety.- Social-Media for Drug Safety.- Blockchain for Drug Safety.- Technology for Drug Safety: Challenges and Recommendations.

    1 in stock

    £37.99

  • Pharmaceutical Manufacturing Deviation and

    Springer Pharmaceutical Manufacturing Deviation and

    1 in stock

    Book SynopsisChapter 1: Initial Actions and Information Gathering.- Chapter 2: Root Cause Analysis (RCA) Methods.- Chapter 3: Analytical Tools for Investigation and Generation of Supporting Evidence.- Chapter 4: Management of Deviation and Failure Investigation.- Chapter 5: Post-RCA Impact Assessment, CAPA, and Effectiveness Checks.- Chapter 6: Case Study: Dissolution OOT Observed for an Extended-Release Tablet Formulation.- Chapter 7: Case Study: OOS Uniformity of Dosage Units (Stratified Samples) for a Capsule Formulation.- Appendix I: Non-Conformance/Deviation Investigation.- Appendix II: OOS Failure Investigation.- Appendix III: Review of CDMO Investigation Report.

    1 in stock

    £80.99

  • Medicinal Plants and Their Bioactives in Human Diseases

    Springer Medicinal Plants and Their Bioactives in Human Diseases

    3 in stock

    Book SynopsisChapter 1: Historical overview and Current trends in use of medicinal plants.- Chapter 2: Safety, toxicity and regulation in use of medicinal plants.- Chapter 3: Mechanisms of Hepatoprotection: Key Phytochemicals and Pathways.- Chapter 4: Plant-Based Remedies for Non-Alcoholic Fatty Liver Disease (NAFLD).- Chapter 5: Phytochemicals in Prevention and Management of Cardiovascular Disease.- Chapter 6: Clinical Trials and Future Directions in herbal treatments against Hepatic and Cardiovascular disease.- Chapter 7: Antibacterial Phytochemicals: A New Era in Infection Management.- Chapter 8: Understanding Fungal Pathogens and Their Challenges in Therapy.- Chapter 9: Synergistic Effects of Medicinal Plants with Conventional Antibiotics against bacterial and fungal infections.- Chapter 10: Safety, Dosage, and Regulatory Aspects in the Use of Phytochemicals.- Chapter 11: Medicinal plants and Phytochemicals Targeting Specific Cancer Pathways and Mechanisms.- Chapter 12: Medicinal Plants in Combination Therapies for Cancer.- Chapter 13: Emerging Research on Bioactive Compounds and Cancer Stem Cells.- Chapter 14: Safety, Dosage, and Regulatory Aspects in the Use of Phytochemicals against Cancer.- Chapter 15: Phytotherapy for Common Upper Respiratory Infections (URIs).- Chapter 16: Plant-Based Treatments for Asthma and Chronic Obstructive Pulmonary Disease (COPD).- Chapter 17: Antiviral and Immunomodulatory Effects of Medicinal Plants in Respiratory Diseases.- Chapter 18: Comparative Efficacy of Phytochemicals in Respiratory Health.- Chapter 19: Mechanisms of Neuroprotection by Medicinal plants and their phytochemicals.- Chapter 20: Prospects and Challenges in Developing neuroprotective phytomedicines. 

    3 in stock

    £116.99

  • Out of stock

    £999.99

  • Essential Oils: Sources, Production and Applications

    De Gruyter Essential Oils: Sources, Production and Applications

    Book SynopsisEssential oils are simply the volatile oils of plants. These are concentrated liquids contain many terpenes, alkaloids and alcohols etc. Various compounds of essential oils have bioactive properties such as antimicrobial, anti-cancer, anti-diabetic, anti-viral and anti-fungal etc. This book describes the sources of essential oils, extraction and production method, characterizing tools, bioactivity, and various applications in the field of industries, daily usage, agriculture, health, and food.

    £77.85

  • Phytochemicals in Medicinal Plants: Biodiversity, Bioactivity and Drug Discovery

    De Gruyter Phytochemicals in Medicinal Plants: Biodiversity, Bioactivity and Drug Discovery

    Book SynopsisBenefitting from phytochemicals in medicinal plants has lately gained increasingly more global relevance. The medicinal bioactivity might range from wound healing activity to anti-inflammatory and anti-viral effects. This work describes the challenging scientific process of systematic identification and taxonomy through molecular profiling and nanoparticle production from plant extracts until a final use for e.g. cancer or HIV treatment. From the table of contentsPART A: Biodiversity & Traditional Knowledge.__Habitats and Distribution.__Threats and Conservation.__Culture, tradition and indigenous practices.PART B: Phytochemical constituents – Molecules and Characterization Techniques.__Alkaloids & Flavonoids.__Tannin, Saponnin and Taxol.__Terpenoids, Steroids and Phenolic Compounds.__Essential oil and their constituents.__Characterization Techniques used for the analysis of phytochemical constituents.PART C: Medicinal Bioactivity.__Anti-cancerous and Anti HIV activity.__Anti-microbial, Anti-inflammatory and wound healing activity.__Anti-oxidant activity.__Anti-diabetic activity.__Anti-Corona virus and anti-viral activity.PART D: Nanotechnology.__Nano-materials synthesis from medicinal plant extract.__Characterization and activity of medicinal plant based nanoparticles.PART E: Pharmacology/Drug discovery.__Plant phytochemicals in drug discovery.__Extraction and production of drugs.__System pharmacology and drug discovery.

    £85.95

  • Carbon Dots in Biology: Synthesis, Properties, Biological and Pharmaceutical Applications

    De Gruyter Carbon Dots in Biology: Synthesis, Properties, Biological and Pharmaceutical Applications

    Book SynopsisThe research on carbon dots is evolving and expanding very rapidly. A high-tech overview for academia and industry is needed to modernize carbon dots in biological applications. This book covers the use of carbon dots in biology, medicine, and pharmacy: synthesis, properties and applications, obstacles in exploiting these materials, and future research prospects. The reader is able to explore the wide scope of carbon dots in the global market.

    £77.85

  • de Gruyter Biogene Gifte

    Book Synopsis

    £126.64

  • Color Atlas of Pharmacology

    Thieme Publishing Group Color Atlas of Pharmacology

    4 in stock

    Book SynopsisThe Fifth Edition of Luellmann's Color Atlas of Pharmacology has been extensively revised to include all recent advances and new drugs, and the illustrations have been optimized and updated. Each two-page spread presents concise text on the left complemented by detailed full-color illustrations on the right to help users quickly digest important facts and concepts. Color-coded sections provide readers with a helpful framework with which to approach the latest developments in pharmacology. Part 1, General Pharmacology, explains basic aspects, such as drug absorption, distribution, and elimination, along with the molecular mechanisms of drug actions Part 2, Systems Pharmacology, presents the different groups of drugs, emphasizing their functional and therapeutic aspects Part 3, Therapy of Selected Diseases, provides all the relevant information regarding the pharmacological treatment of a large number of conditions Key features: User-friendly format ideal for study and review, self-assessment, and quick reference Completely revised and updated, with 174 color plates New glossary of important and interesting pharmacological terms Updated detailed drug indexes containing current information on drugs listed by both generic and brand names The Fifth Edition of Color Atlas of Pharmacology is an essential study guide and reference for every student, nurse, and practicing physician needing to keep up to date with recent advances in the field.Table of ContentsGeneral Pharmacology 1 History of Pharmacology 2 Drug Sources 3 Drug Administration 4 Cellular Sites of Action 5 Distribution in the Body 6 Drug Elimination 7 Pharmacokinetics 8 Quantification of Drug Action 9 Drug–Receptor Interaction 10 Adverse Drug Effects 11 Drug-independent Effects Systems Pharmacology 12 Sympathetic Nervous System 13 Parasympathetic Nervous System 14 Biogenic Amines 15 Vasodilators 16 Inhibitors of the Renin–Angiotensin–Aldosterone System 17 Drugs Acting on Smooth Muscle 18 Cardiac Drugs 19 Antianemic Agents 20 Antithrombotic Agents 21 Plasma Volume Expanders 22 Drugs Used in Hyperlipoproteinemias 23 Diuretics 24 Water and Electrolyte Disorders 25 Gastrointestinal Tract 26 Drugs Affecting the Motor System 27 Drugs for the Suppression of Pain (Analgesics) 28 Drugs Acting on the Central Nervous System 29 Drugs Affecting the Endocrine System 30 Antibacterial Drugs 31 Antifungal Drugs 32 Antiviral Drugs 33 Antiparasitic Drugs 34 Tropical Diseases 35 Anticancer Drugs 36 Immune Modulators 37 Antidotes 38 "Recreational" Drugs Therapy of Selected Diseases 39 Cardiovascular Diseases 40 Neurological Diseases 41 Eye Diseases 42 Bone Disorders 43 Metabolic Disorders 44 Immune Disorders Further Reading 45 Further Reading Glossary 46 Glossary Drug Index 47 Drug Index Abbreviations 48 Abbreviations

    4 in stock

    £40.38

  • Springer International Publishing AG Toxicological Risk Assessment for Beginners

    Out of stock

    Book SynopsisThis book serves as a comprehensive introductory guide to the practical aspects of risk assessment. Chapters include clearly defined objectives and summaries. The book includes: hazard identification, dose-response, exposure assessment, risk characterization, chemical mixtures, epidemiology, emerging issues and global perspectives with accessible language. The book concludes with a set of hypothetical case studies.Toxicological Risk Assessment for Beginners aims not to create an expert, but rather to provide readers with their first understanding of the risk assessment topic. This book was designed with the student in mind. We simplify a complex process for beginners and balance theory with practical aspects, but remain fluid enough to increase difficulty with case studies. By incorporating an action based, step by step approach to learning the risk assessment process, this book provides its readers with an elementary understanding of how the risk assessment process is initiated, developed and finished, making it a valuable guide for graduate students, post-doctoral fellows and early career scientists in industry.Table of ContentsIntroduction.- Hazard Identification.- Dose-Response.- Exposure Assessment.- Risk Characterization for Human Health Risk Assessments.- Risk Assessment Strategies and Techniques for Combined Exposures.- Use of Epidemiology in Risk Assessment.- Emerging Issues in Risk Assessment.- Risk Assessment in the European Union (EU).- Brief Survey of Global Approaches for Risk Assessment.- Skills Development and Resources for Risk Assessment.- Case Studies Chapter.

    Out of stock

    £999.99

  • Springer International Publishing AG Mass Spectrometry: A Textbook

    1 in stock

    Book SynopsisThis book offers a balanced mixture of practice-oriented information and theoretical background as well as numerous references, clear illustrations, and useful data tables. Problems and solutions are accessible via a special website. This new edition has been completely revised and extended; it now includes three new chapters on tandem mass spectrometry, interfaces for sampling at atmospheric pressure, and inorganic mass spectrometry.Trade Review“This third edition has many sections that make it a practical resource, with information on how to conduct tasks and on new innovations. … this well-conceived text is valuable, well written, and clearly a labor of love. Summing Up: Recommended. Upper-division undergraduates and above; faculty and professionals.” (J. Allison, Choice, Vol. 55 (6), February, 2018)“This book does an excellent job at covering a lot of basic and complex material spanning a wide range of expertise. … This book would be a near ideal selection for those faculty teaching a graduate course in mass spectrometry.” (David C. Muddiman, Analytical and Bioanalytical Chemistry, Vol. 410, 2018)“Mass spectrometry is currently eclipsing all other methods for organic analysis. …The author has managed to create a style and presentation that is both pleasing and effective. … recommending it to chemists of all levels interested in mass spectrometry.” (Colin F. Poole, Chromatographia, Vol. 81 (2018)Table of ContentsIntroduction.- Principles of Ionization and Ion Dissociation.- Isotopic Composition and Accurate Mass.- Instrumentation.- Practical Aspects of Electron Ionization.- Fragmentation of Organic Ions and Interpretation of EI Mass Spectra.- Chemical Ionization.- Field Ionization and Field Desorption.- Tandem Mass Spectrometry.- Fast Atom Bombardment.- Matrix-Assisted Laser Desorption/Ionization.- Electrospray Ionization.- Ambient Mass Spectrometry.- Hyphenated Methods.- Inorganic Mass Spectrometry.

    1 in stock

    £98.99

  • Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Drugs and Poisons in Humans: A Handbook of Practical Analysis

    1 in stock

    Book SynopsisUnique analysis of drugs and poisons to facilitate testing in all laboratories even by inexperienced chemists Includes source of chemicals needed for the experiments Texts are composed by 67 experts in analyzing the respective compounds Clear and uniform structure of chapters for ease of reading The text is illustrated by many diagrams and tablesTable of ContentsChapters of general nature 1) How to handle biological specimens 2) Alternative specimens 3) Pitfalls and cautions in analysis of drugs and poisons 4) Pretreatments of human specimens 5) Detection methods 6) A computer system for diagnosis of causative drugs and poisons developed by the Japan Poison Information Center (Tokyo) 7) Practical use of the poison-net developed by the Japan Poison Information Network (Hiroshima) 8) Problems in toxin analysis in emergency medicine 9) Analyses of chemical weapons and their related compounds Chapters on specific toxins 1. Volatile compounds 1) Carbon monoxide 2) Hydrogen sulfide and its metabolites 3) Cyanide 4) Methanol and formic acid 5) Ethanol 6) Chloroform and dichloromethane 7) Toluene, benzene, xylene and stylene 8) Alkyl nitrites 9) Compenents of gasoline and kerosene 2. Controlled drugs 1) Amphetamines and their metabolites 2) Cannabinoids and their metabolites 3) Morphine and its analogues 4) Cocaine and its metabolites 5) Pentazocine 6) Lysergic acid diethylamide (LSD) 7) 3,4-Methylenedioxyamphetamines 8) Phencyclidine 9) ?- Hydroxybutyric acid 3. Psychopharmaceuticals and hypnotics 1) Phenothiazines 2) Butyrophenones 3) Tricyclic and tetracyclic antidepressants 4) Benzodiazepines 5) Bromisovalum 6) Barbiturates 4. General drugs 1) Diphenylmethane antihistaminics 2) Propionic acid derivative analgesic-antipyretics 3) Acetaminophen (paracetamol) 4) Acetylsalicylic acid 5) Antiepileptics 6) Muscle relaxants 7) ß- Blockers 8) Local anaesthetics 9) Salicylicacid 10) ß- Lactam antibiotics 5. Chemicals of daily necessaries 1) Hypochlorite 2) Benzalkonium chlorides 3) Hair dyes 4) Permethrin 5) Boric acid 6) Naphthalene 7) p-Dichlorobenzene 8) Ethylene glycol 6. Natural toxins and alkaloids 1) Aconite toxins 2) Mushroom toxins 3) Tetrodotoxin 4) Methylxanthine derivatives 5) Nicotine and cotinine 6) Tropane alkaloids 7) Oleander toxins 7. Pesticides 1) Simultaneous analysis of pesticides by GC/MS 2) Organophosphorus pesticides 3) Glufosinate and glyphosate 4) Carbamate pesticides 5) Paraquat and diquat 6) Cresol 7) Diazine and triazine herbicides 8) Coumarin rodenticides 8. Miscellaneous 1) Sarin and its decomposition products 2) VX and its decomposition products 3) Sodium azide 4) Arsenic compounds and other inorganic poisons 5) Nitrate and nitrite compounds 6) Methemoglobin

    1 in stock

    £224.99

  • Modern Anesthetics

    Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Modern Anesthetics

    3 in stock

    Book SynopsisSome important constraints of anesthesia must be taken into consideration when the pharmacological properties of modern anesthetics are discussed. The most imp- tant of these could be that the target effect be achieved preferably within seconds, at most within a few minutes. Similarly, offset of drug action should be achieved within minutes rather hours. The target effects, such as unconsciousness, are pot- tially life-threatening, as are the side effects of modern anesthetics, such as respi- tory and cardiovascular depression. Finally, the patient’s purposeful responses are not available to guide drug dosage, because, either the patient is unconscious, or more problematically, the patient is aware but unable to communicate pain because of neuromuscular blockade. These constraints were already recognised 35 years ago, when in 1972 Volume XXX entitled “Modern Inhalation Anesthetics” appeared in this Handbook Series. The present volume is meant as a follow up and extension of that volume. At the beginning of the 1970’s anesthesia was commonly delivered by inhalation, with only very few exceptions. The clinical understanding of that time considered anesthesia as a unique state achieved by any of the inhalation anesthetics, in- pendent of their specific molecular structure. “The very mechanism of anesthetic action at the biophase” was discussed within the theoretical framework of the “u- tary theory of narcosis”.Table of ContentsMolecular Mechanisms of Anesthetic Action.- The Site of Anesthetic Action.- Inhibitory Ligand-Gated Ion Channels as Substrates for General Anesthetic Actions.- Actions of Anesthetics on Excitatory Transmitter-Gated Channels.- Voltage-Gated Ion Channels.- G-Protein-Coupled Receptors.- Modern Inhalation Anesthetics.- Inhalation Anaesthesia: From Diethyl Ether to Xenon.- General Anesthetics and Long-Term Neurotoxicity.- Special Aspects of Pharmacokinetics of Inhalation Anesthesia.- Inhalational Anaesthetics and Cardioprotection.- Non-Immobilizing Inhalational Anesthetic-Like Compounds.- Modern Intravenous Anesthetics.- Propofol.- Pharmacokinetics and Pharmacodynamics of GPI 15715 or Fospropofol (Aquavan Injection) — A Water-Soluble Propofol Prodrug.- Etomidate and Other Non-Barbiturates.- Remifentanil and Other Opioids.- Ketamine.- Midazolam and Other Benzodiazepines.- Pharmacokinetics-Pharmacodynamics Based Administration of Anesthetics.- The Effect of Altered Physiological States on Intravenous Anesthetics.- Anesthetics Drug Pharmacodynamics.- Defining Depth of Anesthesia.- Target Controlled Anaesthetic Drug Dosing.- Advanced Technologies and Devices for Inhalational Anesthetic Drug Dosing.- Hypnotic and Opioid Anesthetic Drug Interactions on the CNS, Focus on Response Surface Modeling.

    3 in stock

    £474.99

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account